Fig. 3From: Enhanced antitumor activity of a novel, oral, helper epitope-containing WT1 protein vaccine in a model of murine leukemiaProportions of WT1-specific CTL phenotypes in PB at weeks 4 (A) and 6 (B) of oral administration. Values are expressed as mean ± SE. *: p < 0.05. WT1, Wilms’ tumor 1; CTL, cytotoxic T lymphocyte; PB, peripheral bloodBack to article page